ES2047864T3 - Procedimiento para la preparacion de un adsorbato de resina de ranitidina. - Google Patents

Procedimiento para la preparacion de un adsorbato de resina de ranitidina.

Info

Publication number
ES2047864T3
ES2047864T3 ES90312263T ES90312263T ES2047864T3 ES 2047864 T3 ES2047864 T3 ES 2047864T3 ES 90312263 T ES90312263 T ES 90312263T ES 90312263 T ES90312263 T ES 90312263T ES 2047864 T3 ES2047864 T3 ES 2047864T3
Authority
ES
Spain
Prior art keywords
preparation
procedure
ramitidine
resin
resin adsorbate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90312263T
Other languages
English (en)
Inventor
Stephen John Douglas
Fiona Ruth Bird
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2047864T3 publication Critical patent/ES2047864T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Furan Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCESO PARA LA PREPARACION DE UN ABSORBENTE DE RESINA DE RAMITIDINA Y UNA RESINA DE INTERCAMBIO DE CATION SINTETICO QUE OCULTA EL SABOR AMARGO ASOCIADO A LA RAMITIDINA. LA RESINA SE PONE EN CONTACTO CON LA RAMITIDINA EN PRESENCIA DE UN SOLVENTE ALCOHOLICO POR LO QUE SE PRODUCE UN ABSORBENTE DE RESINA DE BAJO CONTENIDO DE AGUA, GENERALMENTE MENOS DE 3%.
ES90312263T 1989-11-10 1990-11-09 Procedimiento para la preparacion de un adsorbato de resina de ranitidina. Expired - Lifetime ES2047864T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898925484A GB8925484D0 (en) 1989-11-10 1989-11-10 Process

Publications (1)

Publication Number Publication Date
ES2047864T3 true ES2047864T3 (es) 1994-03-01

Family

ID=10666117

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90312263T Expired - Lifetime ES2047864T3 (es) 1989-11-10 1990-11-09 Procedimiento para la preparacion de un adsorbato de resina de ranitidina.

Country Status (9)

Country Link
EP (1) EP0431759B1 (es)
JP (1) JPH03206037A (es)
AT (1) ATE99925T1 (es)
AU (1) AU6652790A (es)
CA (1) CA2029667A1 (es)
DE (1) DE69005993T2 (es)
DK (1) DK0431759T3 (es)
ES (1) ES2047864T3 (es)
GB (1) GB8925484D0 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104042D0 (en) * 1991-02-26 1991-04-10 Abbott Lab Taste-masked buflomedil preparation
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
CN1615156B (zh) * 2002-01-18 2012-05-30 罗门哈斯公司 制备树脂酸酯的方法
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838952A (en) * 1957-10-03 1960-06-22 Clinical Products Ltd Resin-drug compounds
FR1335502A (fr) * 1960-06-02 1963-08-23 Merck & Co Inc Nouveaux composés d'adsorption de la nicotinamide
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
GB1462356A (en) * 1973-07-10 1977-01-26 Beecham Group Ltd Pharmaceutical compositions
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it

Also Published As

Publication number Publication date
GB8925484D0 (en) 1989-12-28
CA2029667A1 (en) 1991-05-11
AU6652790A (en) 1991-05-16
ATE99925T1 (de) 1994-01-15
DK0431759T3 (da) 1994-02-28
DE69005993T2 (de) 1994-05-05
EP0431759B1 (en) 1994-01-12
JPH03206037A (ja) 1991-09-09
EP0431759A1 (en) 1991-06-12
DE69005993D1 (de) 1994-02-24

Similar Documents

Publication Publication Date Title
SE8901671L (sv) Laekemedelsadsorbat
JPS6490123A (en) Nitroglycerol spray agent
GB8720704D0 (en) Hard tissue substitute composition
ES523741A0 (es) Un procedimiento para producir dispersiones acuosas estables de poliuretanos que contienen en la macromolecula grupos ionicos hidrofilicos.
NL193307B (nl) Bruispreparaat met analgetische werkzaamheid.
ES2048588T3 (es) Composicion bebible baja en calorias.
DK0736033T3 (da) Hidtil ukendte terapeutiske carbohydratblandinger, som er nyttige til afhjælpning af præmenstruelt syndrom
ES2047864T3 (es) Procedimiento para la preparacion de un adsorbato de resina de ranitidina.
EP0191357A3 (en) Treatment of eye inflammation with biphenamine
ES2111032T5 (es) Carboxialquil polisacaridos y procedimiento de fabricacion de los mismos.
KR870000015A (ko) 쑥차의 제조방법
ES2010209B3 (es) Composicion de aroma, el uso de la misma y el procedimiento para su preparacion.
IL85109A (en) Ypsilon-glutamyltranspeptidase,its preparation and its use
FI861881A0 (fi) Saett att framstaella foer natriumditionitframstaellning anvaendbara kompositioner och anvaendningen av saodana kompositioner.
KR870000065A (ko) 약산성 목욕탕수 형성제
AU571205B2 (en) Pyrethroid pharmaceutical composition
KR890009395A (ko) 흡입제
FI903660A0 (fi) Foerfarande foer hydrering av nitroaromatiska halogenderivat i naervaro av jodider.
IL79207A (en) Geriatric pharmaceutical compositions containing terguride for treatment of cognitive and psychic disorders due to dopamine hypofunction
JPS5484023A (en) Soft capsule containing active vitamin d3, and its preparation
JPS53113082A (en) Immobilization of a-1,6-glucosidase obtained by bacteria
GR3001613T3 (en) A "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) for use in therapy by topical application
JPS5480498A (en) Preparation of concentrated soy sauce
KR890002173A (ko) 소디움 아목시실린의 제조방법
JPS55153592A (en) Preparation of plasminogen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 431759

Country of ref document: ES